Opportunities and challenges associated with clinical diagnostic genome sequencing

A report of the association for molecular pathology

Iris Schrijver, Nazneen Aziz, Daniel H. Farkas, Manohar Furtado, Andrea Ferreira Gonzalez, Timothy Charles Greiner, Wayne W. Grody, Tina Hambuch, Lisa Kalman, Jeffrey A. Kant, Roger D. Klein, Debra G B Leonard, Ira M. Lubin, Rong Mao, Narasimhan Nagan, Victoria M. Pratt, Mark E. Sobel, Karl V. Voelkerding, Jane S. Gibson

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

This report of the Whole Genome Analysis group of the Association for Molecular Pathology illuminates the opportunities and challenges associated with clinical diagnostic genome sequencing. With the reality of clinical application of next-generation sequencing, technical aspects of molecular testing can be accomplished at greater speed and with higher volume, while much information is obtained. Although this testing is a next logical step for molecular pathology laboratories, the potential impact on the diagnostic process and clinical correlations is extraordinary and clinical interpretation will be challenging. We review the rapidly evolving technologies; provide application examples; discuss aspects of clinical utility, ethics, and consent; and address the analytic, postanalytic, and professional implications.

Original languageEnglish (US)
Pages (from-to)525-540
Number of pages16
JournalJournal of Molecular Diagnostics
Volume14
Issue number6
DOIs
StatePublished - Jan 1 2012

Fingerprint

Molecular Pathology
Clinical Ethics
Genome
Genome-Wide Association Study
Technology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine

Cite this

Opportunities and challenges associated with clinical diagnostic genome sequencing : A report of the association for molecular pathology. / Schrijver, Iris; Aziz, Nazneen; Farkas, Daniel H.; Furtado, Manohar; Gonzalez, Andrea Ferreira; Greiner, Timothy Charles; Grody, Wayne W.; Hambuch, Tina; Kalman, Lisa; Kant, Jeffrey A.; Klein, Roger D.; Leonard, Debra G B; Lubin, Ira M.; Mao, Rong; Nagan, Narasimhan; Pratt, Victoria M.; Sobel, Mark E.; Voelkerding, Karl V.; Gibson, Jane S.

In: Journal of Molecular Diagnostics, Vol. 14, No. 6, 01.01.2012, p. 525-540.

Research output: Contribution to journalArticle

Schrijver, I, Aziz, N, Farkas, DH, Furtado, M, Gonzalez, AF, Greiner, TC, Grody, WW, Hambuch, T, Kalman, L, Kant, JA, Klein, RD, Leonard, DGB, Lubin, IM, Mao, R, Nagan, N, Pratt, VM, Sobel, ME, Voelkerding, KV & Gibson, JS 2012, 'Opportunities and challenges associated with clinical diagnostic genome sequencing: A report of the association for molecular pathology', Journal of Molecular Diagnostics, vol. 14, no. 6, pp. 525-540. https://doi.org/10.1016/j.jmoldx.2012.04.006
Schrijver, Iris ; Aziz, Nazneen ; Farkas, Daniel H. ; Furtado, Manohar ; Gonzalez, Andrea Ferreira ; Greiner, Timothy Charles ; Grody, Wayne W. ; Hambuch, Tina ; Kalman, Lisa ; Kant, Jeffrey A. ; Klein, Roger D. ; Leonard, Debra G B ; Lubin, Ira M. ; Mao, Rong ; Nagan, Narasimhan ; Pratt, Victoria M. ; Sobel, Mark E. ; Voelkerding, Karl V. ; Gibson, Jane S. / Opportunities and challenges associated with clinical diagnostic genome sequencing : A report of the association for molecular pathology. In: Journal of Molecular Diagnostics. 2012 ; Vol. 14, No. 6. pp. 525-540.
@article{1e9a61bd997743f2ac45b70d064da201,
title = "Opportunities and challenges associated with clinical diagnostic genome sequencing: A report of the association for molecular pathology",
abstract = "This report of the Whole Genome Analysis group of the Association for Molecular Pathology illuminates the opportunities and challenges associated with clinical diagnostic genome sequencing. With the reality of clinical application of next-generation sequencing, technical aspects of molecular testing can be accomplished at greater speed and with higher volume, while much information is obtained. Although this testing is a next logical step for molecular pathology laboratories, the potential impact on the diagnostic process and clinical correlations is extraordinary and clinical interpretation will be challenging. We review the rapidly evolving technologies; provide application examples; discuss aspects of clinical utility, ethics, and consent; and address the analytic, postanalytic, and professional implications.",
author = "Iris Schrijver and Nazneen Aziz and Farkas, {Daniel H.} and Manohar Furtado and Gonzalez, {Andrea Ferreira} and Greiner, {Timothy Charles} and Grody, {Wayne W.} and Tina Hambuch and Lisa Kalman and Kant, {Jeffrey A.} and Klein, {Roger D.} and Leonard, {Debra G B} and Lubin, {Ira M.} and Rong Mao and Narasimhan Nagan and Pratt, {Victoria M.} and Sobel, {Mark E.} and Voelkerding, {Karl V.} and Gibson, {Jane S.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.jmoldx.2012.04.006",
language = "English (US)",
volume = "14",
pages = "525--540",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "6",

}

TY - JOUR

T1 - Opportunities and challenges associated with clinical diagnostic genome sequencing

T2 - A report of the association for molecular pathology

AU - Schrijver, Iris

AU - Aziz, Nazneen

AU - Farkas, Daniel H.

AU - Furtado, Manohar

AU - Gonzalez, Andrea Ferreira

AU - Greiner, Timothy Charles

AU - Grody, Wayne W.

AU - Hambuch, Tina

AU - Kalman, Lisa

AU - Kant, Jeffrey A.

AU - Klein, Roger D.

AU - Leonard, Debra G B

AU - Lubin, Ira M.

AU - Mao, Rong

AU - Nagan, Narasimhan

AU - Pratt, Victoria M.

AU - Sobel, Mark E.

AU - Voelkerding, Karl V.

AU - Gibson, Jane S.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - This report of the Whole Genome Analysis group of the Association for Molecular Pathology illuminates the opportunities and challenges associated with clinical diagnostic genome sequencing. With the reality of clinical application of next-generation sequencing, technical aspects of molecular testing can be accomplished at greater speed and with higher volume, while much information is obtained. Although this testing is a next logical step for molecular pathology laboratories, the potential impact on the diagnostic process and clinical correlations is extraordinary and clinical interpretation will be challenging. We review the rapidly evolving technologies; provide application examples; discuss aspects of clinical utility, ethics, and consent; and address the analytic, postanalytic, and professional implications.

AB - This report of the Whole Genome Analysis group of the Association for Molecular Pathology illuminates the opportunities and challenges associated with clinical diagnostic genome sequencing. With the reality of clinical application of next-generation sequencing, technical aspects of molecular testing can be accomplished at greater speed and with higher volume, while much information is obtained. Although this testing is a next logical step for molecular pathology laboratories, the potential impact on the diagnostic process and clinical correlations is extraordinary and clinical interpretation will be challenging. We review the rapidly evolving technologies; provide application examples; discuss aspects of clinical utility, ethics, and consent; and address the analytic, postanalytic, and professional implications.

UR - http://www.scopus.com/inward/record.url?scp=84867350321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867350321&partnerID=8YFLogxK

U2 - 10.1016/j.jmoldx.2012.04.006

DO - 10.1016/j.jmoldx.2012.04.006

M3 - Article

VL - 14

SP - 525

EP - 540

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 6

ER -